X4 Pharmaceuticals Files 8-K: Material Agreement & Exhibits
Ticker: XFOR · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1501697
| Field | Detail |
|---|---|
| Company | X4 Pharmaceuticals, Inc (XFOR) |
| Form Type | 8-K |
| Filed Date | Jun 23, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing, corporate-update
TL;DR
X4 Pharma filed an 8-K on 6/23 for a material agreement. Big news pending.
AI Summary
On June 23, 2025, X4 Pharmaceuticals, Inc. filed an 8-K report. The filing indicates an entry into a material definitive agreement and includes financial statements and exhibits. The company, formerly known as Arsanis, Inc., is incorporated in Delaware and headquartered in Boston, MA.
Why It Matters
This filing signals a significant contractual development for X4 Pharmaceuticals, potentially impacting its operations and financial standing.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, requiring further analysis of the agreement's terms.
Key Numbers
- 001-38295 — SEC File Number (Identifies the company's filing with the SEC.)
- 27-3181608 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- X4 Pharmaceuticals, Inc. (company) — Registrant
- Arsanis, Inc. (company) — Former company name
- June 23, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Boston, Massachusetts (location) — Principal executive offices
FAQ
What is the nature of the material definitive agreement entered into by X4 Pharmaceuticals?
The filing indicates an 'Entry into a Material Definitive Agreement' as an item of disclosure, but the specific details of the agreement are not provided in this summary.
When was this 8-K filing submitted?
The filing was submitted on June 23, 2025.
What was X4 Pharmaceuticals' former name?
X4 Pharmaceuticals, Inc. was formerly known as Arsanis, Inc.
Where are X4 Pharmaceuticals' principal executive offices located?
The company's principal executive offices are located at 61 North Beacon Street, 4th Floor, Boston, Massachusetts 02134.
What is the SIC code for X4 Pharmaceuticals?
The Standard Industrial Classification (SIC) code for X4 Pharmaceuticals is 2836, which corresponds to BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding X4 Pharmaceuticals, Inc (XFOR).